These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31696703)

  • 1. Mitochondrion-Targeting Peptides and Peptidomimetics: Recent Progress and Design Principles.
    Kim S; Nam HY; Lee J; Seo J
    Biochemistry; 2020 Jan; 59(3):270-284. PubMed ID: 31696703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
    Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
    Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of Stapled Peptides and Small Molecules to Inhibit Protein-Protein Interactions in Cancer.
    Iyer VV
    Curr Med Chem; 2016; 23(27):3025-3043. PubMed ID: 27356541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetic toolbox for drug discovery.
    Lenci E; Trabocchi A
    Chem Soc Rev; 2020 Jun; 49(11):3262-3277. PubMed ID: 32255135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting malignant mitochondria with therapeutic peptides.
    Constance JE; Lim CS
    Ther Deliv; 2012 Aug; 3(8):961-79. PubMed ID: 22946430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
    Mizuno A; Matsui K; Shuto S
    Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-aided design of amino acid-based therapeutics: a review.
    Farhadi T; Hashemian SM
    Drug Des Devel Ther; 2018; 12():1239-1254. PubMed ID: 29795978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists.
    Våbenø J; Haug BE; Rosenkilde MM
    Future Med Chem; 2015; 7(10):1261-83. PubMed ID: 26144264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
    Zielonka J; Joseph J; Sikora A; Hardy M; Ouari O; Vasquez-Vivar J; Cheng G; Lopez M; Kalyanaraman B
    Chem Rev; 2017 Aug; 117(15):10043-10120. PubMed ID: 28654243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of drugs and macromolecules to the mitochondria for cancer therapy.
    Lu P; Bruno BJ; Rabenau M; Lim CS
    J Control Release; 2016 Oct; 240():38-51. PubMed ID: 26482081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered Cell-Penetrating Peptides for Mitochondrion-Targeted Drug Delivery in Cancer Therapy.
    Xiao Q; Dong X; Yang F; Zhou S; Xiang M; Lou L; Yao SQ; Gao L
    Chemistry; 2021 Oct; 27(59):14721-14729. PubMed ID: 34436802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial-targeted penetrating peptide delivery for cancer therapy.
    Wu J; Li J; Wang H; Liu CB
    Expert Opin Drug Deliv; 2018 Oct; 15(10):951-964. PubMed ID: 30173542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Penetrating Mitochondrion-Targeting Ligands for the Universal Delivery of Small Molecules, Proteins and Nanomaterials.
    Xiao Q; Du W; Dong X; Du S; Ong SY; Tang G; Zhang C; Yang F; Li L; Gao L; Yao SQ
    Chemistry; 2021 Aug; 27(47):12207-12214. PubMed ID: 34115398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches.
    Khan T; Waseem R; Zehra Z; Aiman A; Bhardwaj P; Ansari J; Hassan MI; Islam A
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions in interleukin and toll-like receptor signaling pathways.
    Snyder GA; Sundberg EJ
    Curr Pharm Des; 2014; 20(8):1244-58. PubMed ID: 23713776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the activity of mitochondria-penetrating peptides for delivery or disruption.
    Horton KL; Pereira MP; Stewart KM; Fonseca SB; Kelley SO
    Chembiochem; 2012 Feb; 13(3):476-85. PubMed ID: 22238158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondria-targeted drug delivery system for cancer treatment.
    Chen ZP; Li M; Zhang LJ; He JY; Wu L; Xiao YY; Duan JA; Cai T; Li WD
    J Drug Target; 2016; 24(6):492-502. PubMed ID: 26548930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tailoring peptidomimetics for targeting protein-protein interactions.
    Akram ON; DeGraff DJ; Sheehan JH; Tilley WD; Matusik RJ; Ahn JM; Raj GV
    Mol Cancer Res; 2014 Jul; 12(7):967-78. PubMed ID: 24642350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.